Skip to main content
. 2000 Nov;44(11):3118–3121. doi: 10.1128/aac.44.11.3118-3121.2000

TABLE 1.

Susceptibilities of Salmonella serovar Typhimurium isolates to antibiotics, detergents, and dyes

Isolatea MICb
Antibiotics (μg/ml)
Dyes (μg/ml)
Detergents (mg/ml)
NAL CIP TET CHL FOX AMC ERY RIF NOV ACF MB EtBr AO DHCO CTAB SDS NP-40
L3 8 0.03 4 2 1 1 2 16 32 64 128 32 128 1 16 0.25 2
L5 16 0.25 8 64 64 2 4 32 32 64 128 32 128 1 16 0.25 2
L6 64 0.25 8 32 16 4 512 16 256 >512 128 >512 >512 >16 >16 16 >16
L10 32 0.12 16 32 16 4 512 32 512 >512 >512 >512 >512 2 >16 2 16
L12 32 0.5 16 32 16 4 512 16 256 >512 >512 >512 >512 4 >16 16 >16
L15 32 0.25 8 32 8 2 4 16 256 >512 >512 >512 >512 2 >16 16 >16
L18 32 0.5 16 32 32 16 32 16 32 256 128 32 128 1 4 0.25 2
L19 2 0.03 2 2 1 1 16 128 16 512 >512 >512 >512 1 >16 0.25 2
T39 16 1 8 32 32 4 512 128 256 >512 >512 >512 >512 2 16 1 4
LX1054 16 0.25 2 2 2 2 4 16 16 64 32 32 128 1 4 0.5 2
a

L3, pretherapy parent isolate; L5, L6, L10, L12, L15, and L18, posttherapy isolates; L19, Salmonella serovar Typhimurium NCTC 74. T39 (parent strain) and LX1054 (acrB mutant) were from Lacroix et al. (16). 

b

NAL, nalidixic acid; CIP, ciprofloxacin; TET, tetracycline; CHL, chloramphenicol; FOX, cefoxitin; AMC, ampicillin; ERY, erythromycin; RIF, rifampin; NOV, novobiocin; ACF, acriflavine; MB, methylene blue; EtBr, ethidium bromide; AO, acridine orange; DHCO, dehydrocholic acid; SDS, sodium dodecyl sulfate; NP-40, Nonidet P-40. 

HHS Vulnerability Disclosure